PATENT CLAIM ANALYSIS

Application Number: 15883798
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "653000"]

Abstract:
The inventive subject matter is directed to compositions and methods for ready-to-inject norepinephrine compositions with improved stability. Most preferably, compositions presented herein are substantially antioxidant free and exhibit less than 10% isomerization of R-norepinephrine and exhibit less than 5% degradation of total norepinephrine.

Claim (Index 16):
The method of  claim 13  wherein the step of formulating the liquid parenteral composition uses deoxygenated water having dissolved oxygen at a concentration of equal or less than 1 ppm.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 86.0
- Lexical Diversity: 1.2973
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14837749', '15663246', '13704145', '14668683', '15058602']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7416817920117488
- 35 USC 102 Novelty (BERT): 0.514505183585975
- Combined Prediction Score: 0.7189641311691713
- Mean Citation Score: 204.382542
- Max Citation Score: 253.47609
- Similarity Product: 155.04079332049727

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test